
September 27, 2014	Web Version \| Share with a colleague \| eNews Subscribe	You are subscribed to the FormularyWatch eNews

Glucose monitoring system cleared for use in hospital critical care units

A new indication for the Nova StatStrip Glucose Hospital Meter System (Nova Biomedical) has been cleared by FDA. The agency has extended its use to hospitalized patients who are critically ill. » This is the first FDA clearance of a blood glucose monitoring system for use in these patients

Otezla approved for plaque psoriasis

FDA has approved Otezla (apremilast, Celgene) for treating moderate-to-severe plaque psoriasis in patients who are considered candidates for systemic therapy or phototherapy.
» FDA based the approval on two phase 3 trials

#icymi